Deubiquitylating Enzymes in Hepatocellular Carcinoma
- PMID: 40607251
- PMCID: PMC12210126
- DOI: 10.7150/ijbs.113193
Deubiquitylating Enzymes in Hepatocellular Carcinoma
Abstract
Ubiquitination is a reversible and dynamic process, precisely regulated by ubiquitin-activating enzymes (E1), ubiquitin-conjugating enzymes (E2), ubiquitin ligases (E3), and deubiquitinating enzymes (DUBs). Dysregulation of DUBs disrupts the dynamic balance of ubiquitination, contributing to the development of various diseases, particularly cancer. An increasing number of studies have identified dysregulation of DUBs in various tumor types and have explored their regulatory mechanisms in these contexts. Hepatocellular carcinoma (HCC), the most common form of liver cancer, is highly malignant and has limited treatment options, necessitating the exploration of additional therapeutic strategies. Current research has identified dysregulation of DUBs in HCC, but their mechanisms of action remain poorly understood. Given the large number of DUB family members, there is significant potential for further investigation. This review summarizes the DUBs associated with HCC, including their structures, functions, and the mechanisms through which they regulate HCC development. Furthermore, we provide a brief overview of the discussed DUBs, aiming to offer new perspectives for future HCC research.
Keywords: deubiquitylating enzymes; hepatocellular carcinoma.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures


Similar articles
-
OTUD5 promotes the growth of hepatocellular carcinoma by deubiquitinating and stabilizing SLC38A1.Biol Direct. 2024 Apr 24;19(1):31. doi: 10.1186/s13062-024-00475-0. Biol Direct. 2024. PMID: 38658981 Free PMC article.
-
Deubiquitinases in metabolic diseases, fibrosis and cancer of the liver.Biochim Biophys Acta Mol Cell Res. 2025 Oct;1872(7):120021. doi: 10.1016/j.bbamcr.2025.120021. Epub 2025 Jul 11. Biochim Biophys Acta Mol Cell Res. 2025. PMID: 40653113 Review.
-
Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion.Cell Commun Signal. 2024 May 7;22(1):259. doi: 10.1186/s12964-024-01633-7. Cell Commun Signal. 2024. PMID: 38715050 Free PMC article. Review.
-
Dynamic ubiquitination networks in liver cancer: decoding E3 ligases and deubiquitinases as gatekeepers of therapeutic resistance.Med Oncol. 2025 Jul 20;42(8):352. doi: 10.1007/s12032-025-02912-0. Med Oncol. 2025. PMID: 40684404 Review.
-
Deubiquitinating enzymes: Key regulators of ferroptosis and pyroptosis and novel targets for cancer intervention.Int J Biol Sci. 2025 Jun 9;21(9):3993-4009. doi: 10.7150/ijbs.111867. eCollection 2025. Int J Biol Sci. 2025. PMID: 40607253 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical